Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis

4 Jan 2019

Abstract excerpt

Sir, We read with interest the recent article by Ladislau and colleagues reporting on the pathogenicity of type I interferon (IFN) in vitro and evaluating the efficacy of type I interferon pathway blockade for therapeutic purposes in adults with dermatomyositis (Ladislau et al., 2018). The authors demonstrated that activation of type I IFN in differentiating myoblasts abolished myotube formation with reduced...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dupuytren's Contracture and Treatments
Share to Hereditary Neurological Disorders
Share to Inflammatory Myopathies and Dermatomyositis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30715143
DOI: 10.1093/brain/awz005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositisPMID 30715143Read ↗

Current evidence for janus kinase inhibitors in adult and juvenile dermatomyositis and key comparisonsSemantic proximity Read ↗

Successful management with Janus kinase inhibitor tofacitinib in refractory juvenile dermatomyositis: a pilot study and literature reviewSemantic proximity Read ↗

Clinical and Molecular Effects of TYK2/JAK1 Inhibition in DermatomyositisSemantic proximity Read ↗

Immunopathogenesis of juvenile dermatomyositis.Semantic proximity Read ↗

Transcriptomes of peripheral blood mononuclear cells from juvenile dermatomyositis patients show elevated inflammation even when clinically inactiveSemantic proximity Read ↗

Oral Baricitinib in the Treatment of Cutaneous Lichen PlanusSemantic proximity Read ↗

Recent advances in juvenile idiopathic inflammatory myopathies.Semantic proximity Read ↗

Update on juvenile dermatomyositis: new advances in understanding its etiopathogenesis.Semantic proximity Read ↗

The Significance of Autoantibodies in Juvenile Dermatomyositis.Semantic proximity Read ↗

The pathogenesis of dermatomyositis.Semantic proximity Read ↗

Spatial transcriptomic analysis of muscle biopsy from treatment-naive juvenile dermatomyositis patients reveals mitochondrial abnormalities despite disease-related interferon driven signatureSemantic proximity Read ↗

Single nucleus RNA sequencing of juvenile dermatomyositis skeletal muscle identifies altered angiogenic signalingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.